The overall aim of this research is to identify the potential co-occurrence of genomic variants beyond mutations in the SACS gene and the epigenetic effects that might explain the different phenotype severity existing among ARSACS patients.

Grant: $52,000

Duration : one year


Dr. Daniele Galatolo

Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit

IRCCS Stella Maris Foundation

via dei Giacinti 2,

56128 Calambrone (Pisa) – Italy

email :